9-Hydroxyellipticine alters the conformation and DNA binding characteristics of mutated p53 protein

E Sugikawa1, S Tsunoda, N Nakanishi

  • 1Discovery Research Laboratory, Tanabe Seiyaku Co., Ltd., Toda, Saitama, Japan.

Anticancer Research
|November 29, 2001
PubMed

Insights

The cytotoxic agent 9-hydroxyellipticine (9HE) restores tumor suppressor protein p53

Area of Science:

  • Oncology
  • Molecular Biology
  • Biochemistry

Background:

  • The tumor suppressor protein p53 is crucial for preventing cancer.
  • Mutations in p53 are common in human cancers, leading to loss of its tumor-suppressing functions.
  • Restoring p53 function is a key therapeutic goal in cancer treatment.

Purpose of the Study:

  • To investigate the effect of 9-hydroxyellipticine (9HE) on the tertiary structure and DNA binding of mutant p53.
  • To determine if 9HE can restore wild-type-like functions to mutated p53 proteins.

Main Methods:

  • Treatment of cancer cells with 9HE.
  • Analysis of p53 protein stability and degradation by calpain.
  • Assessment of p53 DNA binding affinity to a consensus sequence.

Main Results:

  • Mutant p53 proteins, normally resistant to calpain degradation, became sensitive after 9HE treatment.
  • 9HE treatment restored the ability of mutant p53 to bind to a wild-type p53 DNA consensus sequence.
  • Wild-type p53 showed consistent calpain sensitivity and DNA binding regardless of 9HE treatment.

Conclusions:

  • 9-hydroxyellipticine (9HE) alters the tertiary structure of mutant p53.
  • This structural change restores the DNA binding capacity of mutant p53, suggesting a potential therapeutic strategy for cancers with p53 mutations.

Related Concept Videos

Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
DNA Damage can Stall the Cell Cycle02:36

DNA Damage can Stall the Cell Cycle

In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
DNA Damage Can Stall the Cell Cycle02:36

DNA Damage Can Stall the Cell Cycle

In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
Negative Regulator Molecules01:23

Negative Regulator Molecules

Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
Covalently Linked Protein Regulators02:04

Covalently Linked Protein Regulators

Proteins can undergo many types of post-translational modifications, often in response to changes in their environment. These modifications play an important role in the function and stability of these proteins. Covalently linked molecules include functional groups, such as methyl, acetyl, and phosphate groups, and also small proteins, such as ubiquitin. There are around 200 different types of covalent regulators that have been identified.
These groups modify specific amino acids in a protein.